EASL supports the “Gift of Life”
Together with 21 international medical societies EASL strongly reaffirms the essential values held by the global community of transplant providers. We stand against any form of barriers in access, knowledge, transition and…
EASL makes a statement for the liver at 71st Session of the WHO Regional Committee for Europe
On 14 September 2021, EASL, in its role a non-state actor in official relations with the World Health Organization (WHO), provided a joint statement on matters of considerable importance in liver care: primary health care and keeping viral hepatitis…
Driving progress in cholestatic liver disease: Prof. Peter L. M. Jansen (3 March 1946 – 14 September 2021)
It is with great sadness that EASL announces the passing of Prof. Peter L.M. Jansen, devoted to cholestatic and metabolic liver disease, a longstanding member of the EASL community, and an inspiration…
Showcasing ILC 2021 via the Turkish Association for the Study of the Liver
On 16 October 2021, the best of ILC 2021 will be showcased at an online event jointly run by EASL and the Turkish Association for the Study of the Liver (TASL), called the Best of…
NAFLD Photo competition
Update 15 September: winners of the competition 1st Prize: Charmaine Matthews She will receive a free registration for the NAFLD Summit + a 1-year EASL membership 2nd Prize: Alina Demyanova She will…
An unforgettable lesson
Dear reader, Since its launch, EASL’s Liver Matters blog has been offering you content that veers away from the strictly scientific aspects of hepatology. We’re bringing you voices and views. We’re paying…
New EASL Position Paper provides guidance on systemic treatment of liver cancer
On 10 July 2021, the Journal of Hepatology published a new free-access EASL Position Paper, titled, “Systemic treatment of hepatocellular carcinoma”, by Jordi Bruix et al.
